Comparison of Adalimumab and Infliximab Treatment of Rheumatoid Arthritis

NCT00216177 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

112

Enrollment

OTHER

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Infliximab
DRUG: Adalimumab

Sponsor

Hvidovre University Hospital

Collaborators

[object Object]